{"id":"W2950895705","doi":"10.1097/01.hs9.0000559856.05874.69","title":"PF411 ENESTOP 192‐WK RESULTS: DURABILITY AND IMPACT ON QUALITY OF LIFE OF TREATMENT‐FREE REMISSION (TFR) FOLLOWING SECOND‐LINE (2L) NILOTINIB (NIL) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Nilotinib; Internal medicine; Gastroenterology; Imatinib mesylate; Surgery; Myeloid leukemia; Imatinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005974044,0.000613025,0.001643626,0.0001263247,0.00005409405,0.00001134651,0.0002061444,0.0003155936,0.0005880803],"category_scores_gemma":[0.0007003965,0.0004184037,0.0003306381,0.0004287875,0.0001381341,0.00019663,0.0001155904,0.0003385671,0.00002076909],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007962736,"about_ca_system_score_gemma":0.002661047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004020218,"about_ca_topic_score_gemma":0.001458949,"domain_scores_codex":[0.9961252,0.0002418936,0.001420089,0.0009476736,0.0006885675,0.0005765404],"domain_scores_gemma":[0.9963863,0.000561799,0.0007491121,0.001759423,0.0001633068,0.0003800183],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01297569,0.001400127,0.9684582,0.00129242,0.0004895097,0.00002341887,0.0007646322,0.0002906159,0.00666263,0.00001988854,0.0001971449,0.007425671],"study_design_scores_gemma":[0.07560471,0.01428388,0.8918433,0.001920539,0.000206984,0.00001021424,0.0002904111,0.0002599826,0.01467854,0.00003664469,0.0004188167,0.0004460507],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944503,0.0007880774,0.000002673585,0.00009154116,0.000112307,0.001840506,0.0002346119,0.00005746241,0.00242254],"genre_scores_gemma":[0.9973477,0.00009596095,0.0003897704,0.00004569165,0.00006928312,0.00003551834,0.0002709472,0.00007321791,0.0016719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07661501,"threshold_uncertainty_score":0.9998268,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01876692524407701,"score_gpt":0.2870449102057383,"score_spread":0.2682779849616613,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}